Viracta Therapeutics, Inc.

Viracta Therapeutics, Inc.

VIRX
Viracta Therapeutics, Inc.US flagOther OTC
0.01
USD
- -
- -
388,698.00Market Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
19
26
51
51
+ Selling, General & Admin
5
15
24
17
+ Research & Development
13
24
26
33
+ Other Operating Expense
- -
-14
- -
- -
Operating Income (Loss)
-19
-26
-51
-51
- Non-Operating (Income) Loss
- -
89
-1
- -
+ Interest Expense, Net
- -
- -
-1
- -
+ Interest Expense
- -
- -
1
4
- Interest Income
- -
- -
1
3
+ Other Non-Op (Income) Loss
- -
89
-1
- -
Pretax Income
-19
-115
-49
-51
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-19
-115
-49
-51
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-19
-115
-49
-51
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-19
-115
-49
-51
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-19
-115
-49
-51
EBIT
-19
-26
-51
-51
EBITDA
-19
-26
-50
-50
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
-19
-26
-51
-51
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
37
32
38
39
Basic EPS, GAAP
-0.51
-3.6
-1.3
-1.32
Basic EPS from Cont Ops
-0.51
-3.6
-1.3
-1.32
Diluted Weighted Avg Shares
37
32
38
39
Diluted EPS, GAAP
-0.51
-3.6
-1.3
-1.32
Diluted EPS from Cont Ops
-0.51
-3.6
-1.3
-1.32

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
47
105
94
55
+ Cash, Cash Equivalents & STI
47
104
91
54
+ Cash & Cash Equivalents
47
104
37
12
+ ST Investments
- -
- -
54
41
+ Accounts & Notes Receiv
- -
- -
1
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
1
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
2
2
1
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
1
3
2
2
+ Property, Plant & Equip, Net
1
1
- -
- -
+ Property, Plant & Equip
1
1
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
2
2
1
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
2
2
1
Total Assets
48
109
96
57
+ Payables & Accruals
5
9
10
13
+ Accounts Payable
2
3
3
2
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
3
6
7
10
+ ST Debt
1
- -
- -
26
+ ST Borrowings
1
- -
- -
25
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
Total Current Liabilities
6
9
10
38
+ LT Debt
5
5
25
- -
+ LT Borrowings
4
5
25
- -
+ LT Finance Leases
1
- -
- -
- -
+ Other LT Liabilities
83
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
83
- -
- -
- -
Total Noncurrent Liabilities
88
5
25
- -
Total Liabilities
95
14
35
38
+ Preferred Equity and Hybrid Capital
- -
5
5
5
+ Share Capital & APIC
5
255
271
279
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
5
255
271
279
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-51
-166
-215
-266
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-46
94
61
18
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-46
94
61
18
Total Liabilities & Equity
48
109
96
57
Shares Outstanding
37
37
38
39
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
1
1
- -
- -
Net Debt
-42
-99
-12
13
Net Debt to Equity
90.7
-104.62
-19.47
70.73
Tangible Common Equity Ratio
-95.64
81.91
57.98
22.7
Current Ratio
7.51
11.59
9.36
1.43
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-19
-115
-49
-51
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
- -
94
13
6
+ Stock-Based Compensation
- -
6
14
8
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
89
-1
-2
+ Chg in Non-Cash Work Cap
3
2
1
5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-1
1
+ Inc (Dec) in Accts Payable
3
2
1
3
+ Inc (Dec) in Other
- -
1
1
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-16
-19
-35
-40
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-4
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
-4
- -
- -
+ Cash (Repurchase) of Equity
1
62
2
- -
+ Increase in Capital Stock
1
62
2
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-54
15
+ Dec in LT Investment
- -
- -
17
82
+ Inc in LT Investment
- -
- -
-71
-67
+ Net Cash From Acq & Div
- -
17
- -
- -
+ Cash from Divestitures
- -
17
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
13
-54
15
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
5
- -
20
- -
+ Cash From Debt
5
- -
20
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
39
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
45
62
23
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
29
56
-67
-24
EBITDA
-19
-26
-50
-50
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
-16
-23
-36
-40
Net Cash Paid for Acquisitions
- -
-17
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-14
-16
-40
Free Cash Flow per Basic Share
-0.44
-0.72
-0.94
-1.04
Price/Free Cash Flow
-16.14
-7.97
-1.56
-0.55
Cash Flow to Net Income
0.84
0.16
0.72
0.78
Capital Expenditures
- -
-4
- -
- -